Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah J Morgan

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The Journal of Biological Chemistry|July 27, 2017
<i>De novo</i> triiodothyronine formation from thyrocytes activated by thyroid-stimulating hormoneCintia E Citterio, Balaji Veluswamy, Sarah J Morgan, et al.
Mbio|September 19, 2022
Genome Capture Sequencing Selectively Enriches Bacterial DNA and Enables Genome-Wide Measurement of Intrastrain Genetic Diversity in Human InfectionsHillary S Hayden, Snehal Joshi, Matthew C Radey, et al.
The Journal of Clinical Investigation|March 28, 2023
Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persistDavid P Nichols, Sarah J Morgan, Michelle Skalland, et al.
Annals of the American Thoracic Society|September 17, 2025
Long-term Reductions in Inflammation in People with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/IvacaftorScott D Sagel, T Spencer Poore, Brandie D Wagner, et al.
Plos Pathogens|March 21, 2019
Bacterial fitness in chronic wounds appears to be mediated by the capacity for high-density growth, not virulence or biofilm functionsSarah J Morgan, Soyeon I Lippman, Gilbert E Bautista, et al.
Mbio|December 14, 2021
Combining Ivacaftor and Intensive Antibiotics Achieves Limited Clearance of Cystic Fibrosis InfectionsSamantha L Durfey, Sudhakar Pipavath, Anna Li, et al.
Thorax|October 28, 2021
Testing the effects of combining azithromycin with inhaled tobramycin for <i>P. aeruginosa</i> in cystic fibrosis: a randomised, controlled clinical trialDavid P Nichols, Pradeep K Singh, Arthur Baines, et al.
Cell Host & Microbe|August 6, 2025
Pseudomonas infections persisting after CFTR modulators are widespread throughout the lungs and drive lung inflammationSamantha L Durfey, Siddhartha G Kapnadak, Tahuanty Pena, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of Biological Chemistry|July 27, 2017
<i>De novo</i> triiodothyronine formation from thyrocytes activated by thyroid-stimulating hormoneCintia E Citterio, Balaji Veluswamy, Sarah J Morgan, et al.
Mbio|September 19, 2022
Genome Capture Sequencing Selectively Enriches Bacterial DNA and Enables Genome-Wide Measurement of Intrastrain Genetic Diversity in Human InfectionsHillary S Hayden, Snehal Joshi, Matthew C Radey, et al.
The Journal of Clinical Investigation|March 28, 2023
Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persistDavid P Nichols, Sarah J Morgan, Michelle Skalland, et al.
Annals of the American Thoracic Society|September 17, 2025
Long-term Reductions in Inflammation in People with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/IvacaftorScott D Sagel, T Spencer Poore, Brandie D Wagner, et al.
Plos Pathogens|March 21, 2019
Bacterial fitness in chronic wounds appears to be mediated by the capacity for high-density growth, not virulence or biofilm functionsSarah J Morgan, Soyeon I Lippman, Gilbert E Bautista, et al.
Mbio|December 14, 2021
Combining Ivacaftor and Intensive Antibiotics Achieves Limited Clearance of Cystic Fibrosis InfectionsSamantha L Durfey, Sudhakar Pipavath, Anna Li, et al.
Thorax|October 28, 2021
Testing the effects of combining azithromycin with inhaled tobramycin for <i>P. aeruginosa</i> in cystic fibrosis: a randomised, controlled clinical trialDavid P Nichols, Pradeep K Singh, Arthur Baines, et al.
Cell Host & Microbe|August 6, 2025
Pseudomonas infections persisting after CFTR modulators are widespread throughout the lungs and drive lung inflammationSamantha L Durfey, Siddhartha G Kapnadak, Tahuanty Pena, et al.
Pageof 3